91 related articles for article (PubMed ID: 1598823)
21. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
22. (-)-stepholidine: a dopamine receptor antagonist shows agonistic effect on rotational behavior in 6-hydroxydopamine-lesioned rats.
Huang KX; Sun BC; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Jan; 13(1):17-22. PubMed ID: 1605028
[TBL] [Abstract][Full Text] [Related]
23. Effects of (-)-stepholidine on firing activity of dopamine neurons in ventral tegmental area of rats.
Sun BC; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):395-9. PubMed ID: 1300038
[TBL] [Abstract][Full Text] [Related]
24. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
26. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
Barnett JV; Kuczenski R
J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
[TBL] [Abstract][Full Text] [Related]
28. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
Zou LL; Liu J; Jin GZ
Biochem Pharmacol; 1997 Jul; 54(2):233-40. PubMed ID: 9271327
[TBL] [Abstract][Full Text] [Related]
29. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Dong ZJ; Chen LJ; Jin GZ; Creese I
Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
[TBL] [Abstract][Full Text] [Related]
30. Effect of (-)-stepholidine on serum prolactin level of female rats.
Zou LL; Chen Y; Song YY; Jin GZ
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):311-4. PubMed ID: 9812710
[TBL] [Abstract][Full Text] [Related]
31. Effects of (-)-stepholidine and tetrahydroberberine on high potassium-evoked contraction and calcium influx in rat artery.
Yang S; Miao YS; Han Q; Jiang MH; Jin GZ
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):235-7. PubMed ID: 8237399
[TBL] [Abstract][Full Text] [Related]
32. Characterization of monoaminergic receptors in hypothalamic nuclei mediating feeding behavior in rats.
Carruba MO; Nisoli E; Garosi V; Pizzi M; Memo M; Spano P
J Pharmacol Exp Ther; 1991 Oct; 259(1):124-30. PubMed ID: 1681082
[TBL] [Abstract][Full Text] [Related]
33. Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats.
Zhang XX; Liu J; Fu Y; Hu GY; Jin GZ
Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):979-86. PubMed ID: 11270978
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
35. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
36. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
37. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
Onali P; Olianas MC; Bunse B
Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
[TBL] [Abstract][Full Text] [Related]
38. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies.
Huang KX; Jin GZ
Sci China B; 1992 Jun; 35(6):688-96. PubMed ID: 1510818
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
Sun BC; Jin GZ
Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
[TBL] [Abstract][Full Text] [Related]
40. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
